- Oversee Junshi Biosciences overseas business activities.
- Former Vice President and Head of Region Asia Regulatory Affairs and Medical Policy at Sanofi.
- Former Regulatory Reviewer/Senior Reviewer of Oncology Division and Team Leader and Branch Chief at FDA.
- B.S. in Medicine and M.D. from Shanghai Medical College of Fudan University and Ph.D. in Preventive Medicine from University of Iowa.
![](https://www.topalliancebio.com/wp-content/uploads/2024/07/Portrait_NL-244x300.png)
Ning Li, M.D., Ph.D., Chairman of the Board
![](https://www.topalliancebio.com/wp-content/uploads/2024/07/Portrait_SY-Photoroom-240x300.png)
Sheng Yao, Ph.D., Chief Executive Officer and Executive Director
- Co-founder of Shanghai Junshi Pharma and TopAlliance Biosciences.
- Research fellow in immunology at the Mayo Clinic College of Medicine and Johns Hopkins University.
- Trained under the guidance of immunotherapy pioneer, Dr. Lieping Chen.
- B.S. Biotechnology from Peking University and Ph.D. from Albert Einstein College of Medicine.
![](https://www.topalliancebio.com/wp-content/uploads/2023/10/Potrait_Dr.Patricia-Keegan-502x627-1-240x300.png)
Patricia Keegan ,M.D., Chief Medical Officer
- Former Acting Associate Director of Medical Policy Oncology Center for Excellence (OCE), Office of the Commissioner.
- Division Director of Oncology Products (16 years).
- Deputy Director Division of Clinical Trial Design and Analysis (4 years).
- Chief and Medical Officer at Oncology Branch (8 years)
- Clinical Assistance Professor and Medical Oncologist at University of North Carolina at Chapel Hill.
- B.S. in Biology from University of Illinois Champaign-Urbana and M.D. from Loyola University Stritch School of Medicine
- Completed her residency in internal medicine at the Loyola University Medical Center, Maywood, Illinois, and her fellowship in medical oncology at Roswell Park Memorial Institute, Buffalo, New York
![](https://www.topalliancebio.com/wp-content/uploads/2023/10/Portrait_KL_Sized-241x300.png)
Kevin Li, Ph.D., Vice President of Regulatory Affairs
- Joined TopAlliance since 2020.
- Oversee the all regulatory-related activities.
- Former Director of Regulatory Affairs at AstraZeneca BioVentures and Head of Regulatory Affairs at Centus Biotherapeutics.
- Former Product Quality Reviewer at the Office of Biotechnology Products (OBP) and the Office of Life Cycle Product at CDER/FDA.
- B.S. in Biotechnology from Peking University and Ph.D. from University of Illinois at Urbana-Champaign.
![](https://www.topalliancebio.com/wp-content/uploads/2023/10/Portrait_MH_Sized-241x300.png)
Monica Hughes, Vice President of Project and Portfolio Management
- Responsible for developing and executing the clinical portfolio/project management strategies on behalf of the CMO
- Industry Executive Leadership roles in Regulatory Affairs and Project Management (3 years)
- Chief, Project Management Staff for the Division of Oncology Products 2 in the Office of Oncologic Diseases, CDER, US FDA (8 years)
- Regulatory Project Manager/Team Leader for the Division of Oncology Products 2 in the Office of Oncologic Diseases, CDER, US FDA (10 years)
- B.S. in Combined Science Biology/Chemistry and M.S. in Molecular Biology from Youngstown State University